
Research Highlight: Basal Cell Carcinoma’s Low Immunogenicity Linked to Antigen Presentation Suppression from Its ...
Basal cell carcinoma (BCC) sits at a fascinating crossroads in cancer biology: despite being the most mutated human cancer, it paradoxically exhibits remarkably low immunogenicity, rendering it resistant to many immune-based therapies. This perplexing …